DexCom shares have delivered a mixed ride in recent years, and that uneven path raises a simple question for anyone looking ...

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) announced today the Dexcom G6 Continuous Glucose Monitoring (CGM) System is now available at Veterans Affairs (VA) pharmacies, improving access ...

DexCom stock was trading at USD 87.02 on Nasdaq on September 24, 2026 at 12:02 p.m. ET, down 0.80 percent from the prior ...

Dexcom stock closed at USD 87.73 on the Nasdaq on September 24, 2026, down 2.01 percent from the prior close. The Nasdaq ...

Dexcom ( ) has issued an announcement. On September 10, 2026, Dexcom ’s board appointed Executive Vice President and Chief Financial Officer Jereme Sylvain to the expanded role ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Dexcom (DXCM) and Wave Life Sciences (WVE) with bullish sentiments. According to TipRanks.com, Newitter ...

DexCom is a leader in the continuous glucose monitoring (CGM) systems market. They aren't the only kinds of devices that help diabetes patients keep track of their blood glucose levels -- a necessary ...

SAN DIEGO--(BUSINESS WIRE)--This World Diabetes Day, DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing technology, is encouraging people with diabetes globally to take the first ...

DexCom receives a BUY rating due to strong growth, expanding margins, and the launch of Stelo, the first OTC CGM for non-insulin users. DXCM raised its 2025 outlook, targeting $4.6B+ in revenue, 62% ...

DexCom (NasdaqGS:DXCM) has promoted former Chief Financial Officer Jereme Sylvain to EVP and Chief Operating Officer.

Dexcom shares plunged on disappointing revenue and weak guidance. The stock was down 13% for the year as of Thursday's close. Dexcom makes continuous glucose monitors for patients with diabetes. In ...

Dexcom said Monday it has made Jereme Sylvain chief operating officer, expanding the executive’s role at the diabetes ...